Sign up Australia
Proactive Investors - Run By Investors For Investors

AuMake International calls for trading pause pending business update

The halt will remain in place until Wednesday 10th January 2018.
AuMake International calls for trading pause pending business update
The company's shares are in pre-open

AuMake International Ltd (ASX:AU8) has been granted a trading halt by the ASX this morning, pending details on the current entitlement offer and a business update.

AuMake shares last traded at $0.53, and the current capital raising program is fully-underwritten, but priced at $0.63.

The company is selling its products into China.

The halt will remain in place until the opening of trade on Wednesday 10th January 2018, or earlier if an announcement is made to the market.

View full AU8 profile View Profile

AuMake International Ltd Timeline

Related Articles

scientist in lab
September 07 2018
Normally, patients have to wait until regulators have approved a drug before they get access to it, but up to 500 lupus sufferers will receive Lupuzor as part of a Managed Access Programme
Empty lab
September 19 2018
Management has made some tough decisions, cutting the cost base, since a disappointing first-half performance and expects the benefits to really kick in next year
tumour cells
July 25 2018
Sign-off by the US Food & Drug Administration is considered the "global standard for approval", the company said

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use